Clinical Trial Update: HistScanning- Based PDR Brachytherapy in Prostate Cancer HistoScanning- Based Interstitial PDR Brachytherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HistScanning-based interstitial PDR brachytherapy for prostate cancer; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: University Hospital Erlangen | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN